Astrana Health (ASTH) | Stock Overview & Key Data
Astrana Health Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $133.23 on November 15, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Astrana Health
ASTH
|
1.88B Small-cap | -4.23% | 5.52% | 40.24% | 61.74% | 46.35% | 51.75% | 11.50% | 1.87% | 585.25% | 637.65% | 637.65% |
|
HCA Healthcare
HCA
|
106.00B Large-cap | -6.38% | -14.00% | -31.06% | -26.57% | -21.90% | -0.75% | 38.02% | 77.08% | 384.44% | 1,008.79% | 1,116.39% |
|
Tenet Healthcare
THC
|
16.50B Large-cap | -7.25% | -11.73% | -30.42% | -23.85% | -17.97% | 3.88% | 135.08% | 158.85% | 506.43% | 601.28% | 444.47% |
| 1.91B Small-cap | 0.93% | -2.90% | 11.19% | -8.61% | 2.21% | 52.23% | 53.97% | -32.60% | -68.09% | -39.53% | -4.27% | |
|
Surgery Partners
SGRY
|
1.86B Small-cap | 2.45% | -2.96% | -13.22% | -17.78% | -9.70% | -43.41% | -66.42% | -77.94% | -5.72% | -27.51% | -27.51% |
|
Addus HomeCare
ADUS
|
1.78B Small-cap | -2.93% | -9.66% | -14.07% | -24.67% | -15.13% | -17.34% | -1.54% | -3.40% | 378.00% | 1,453.90% | 901.97% |
Ownership & Short Interest
Calculate Your Astrana Health Investment Returns
Long-Term Investment Performance Analysis
Astrana Health stock price in May 2016 was $5.49, A $1,000.00 lump sum investment in Astrana Health made 10 years ago would be worth approximately $6,679.42 today, representing a exceptional return of 567.94%. This translates to an annualized return (CAGR) of 20.89%.
10 Years Investment Scenario (May 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is ASTH's 52-week high and low?
- In the last 52 weeks, Astrana Health reached a high of $39.93 (on N/A) and a low of $18.08 (on February 12, 2026).
- What is the market cap and P/E ratio for ASTH?
- Curious about Astrana Health's size and valuation? Its market capitalization stands at 1.88B. When it comes to valuation, the P/E ratio (trailing twelve months) is 73.30, and the forward P/E (looking ahead) is 10.50.
- Does ASTH pay dividends? If so, what's the yield?
- As for dividends, Astrana Health isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Astrana Health's main competitors or similar companies to consider before investing?
When looking at Astrana Health, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return HCA Healthcare
HCA106.00B Healthcare Medical Care Facilities -0.75% 38.02% Tenet Healthcare
THC16.50B Healthcare Medical Care Facilities 3.88% 135.08% Pediatrix Medical
MD1.91B Healthcare Medical Care Facilities 52.23% 53.97% Surgery Partners
SGRY1.86B Healthcare Medical Care Facilities -43.41% -66.42% Addus HomeCare
ADUS1.78B Healthcare Medical Care Facilities -17.34% -1.54% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Astrana Health Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Astrana Health's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 4.49%, the Debt to Equity ratio from the most recent quarter is 193.10, and its Gross Profit Margin stands at 10.00%.
- What is the recent revenue and earnings growth for ASTH?
- Looking at Astrana Health's growth, its revenue over the trailing twelve months (TTM) was $3B. Compared to the same quarter last year (YoY), quarterly revenue grew by 42.90%, and quarterly earnings saw a YoY growth of 42.89%.
- How much of ASTH stock is held by insiders and institutions?
- Wondering who owns Astrana Health stock? Company insiders (like executives and directors) hold about 20.32% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 52.52%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.